Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Program Evaluation and Active Adverse Event Surveillance for Initial Implementation of WHO Prequalified ShangRing™ Circumcision in Mozambique

NCT03761836 is registered in ClinicalTrials.gov with Jhpiego as lead sponsor.

NCT NCT03761836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Program Evaluation and Active Adverse Event Surveillance for Initial Implementation of WHO Prequalified ShangRing™ Circumcision in Mozambique
Lead sponsor
Jhpiego
Phase
Not applicable
Overall status
Withdrawn
Start date
November 1, 2020
Completion date
December 30, 2021
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

circumcision, male